Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/36242| Title: | Empagliflozin-Induced Changes in Epicardial Fat The Centerpiece for Myocardial Protection? | Authors: | MULLENS, Wilfried MARTENS, Pieter |
Issue Date: | 2021 | Publisher: | ELSEVIER SCI LTD | Source: | JACC-Heart Failure, 9 (8) , p. 590 -593 | Keywords: | CMR;SGLT2-inhibitors;epicardial adipose tissue;heart failure;myocardial fibrosis;Benzhydryl Compounds;Glucosides;Humans;Myocardium;Heart Failure | Document URI: | http://hdl.handle.net/1942/36242 | ISSN: | 2213-1779 | e-ISSN: | 2213-1787 | DOI: | 10.1016/j.jchf.2021.05.006 | ISI #: | 000678493300006 | Rights: | 2021 by the American College of Cardiology Foundation. Published by Elsevier. | Category: | A2 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Empagliflozin-Induced Changes in Epicardial Fat.pdf | Published version | 714.82 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
21
checked on Aug 31, 2025
WEB OF SCIENCETM
Citations
21
checked on Sep 2, 2025
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.